DK2076532T3 - Cytokinderivater - Google Patents

Cytokinderivater

Info

Publication number: DK2076532T3
Authority: DK; Denmark
Prior art keywords: terminal portion; cytokine derivatives; cytokine; derivatives; polypeptides
Prior art date: 2006-07-25

Application number

DK07825334.1T

Other languages

English (en)

Inventor

Oliver Hartley

Original Assignee

Mintaka Foundation For Medical Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-07-25

Filing date

2007-07-25

Publication date

2011-03-07

2007-07-25 Application filed by Mintaka Foundation For Medical Res filed Critical Mintaka Foundation For Medical Res

2011-03-07 Application granted granted Critical

2011-03-07 Publication of DK2076532T3 publication Critical patent/DK2076532T3/da

Links

102000004127 Cytokines Human genes 0.000 title 1
108090000695 Cytokines Proteins 0.000 title 1
210000004899 c-terminal region Anatomy 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
229920001184 polypeptide Polymers 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
- C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Oncology (AREA)
Pulmonology (AREA)
Virology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Tropical Medicine & Parasitology (AREA)

DK07825334.1T 2006-07-25 2007-07-25 Cytokinderivater DK2076532T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0614755.7A GB0614755D0 (en)	2006-07-25	2006-07-25	Cytokine derivatives
PCT/IB2007/003026 WO2008012689A2 (en)	2006-07-25	2007-07-25	Cytokine derivatives

Publications (1)

Publication Number	Publication Date
DK2076532T3 true DK2076532T3 (da)	2011-03-07

Family

ID=37006114

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07825334.1T DK2076532T3 (da)	2006-07-25	2007-07-25	Cytokinderivater

Country Status (25)

Country	Link
US (2)	US8686111B2 (da)
EP (1)	EP2076532B1 (da)
JP (1)	JP5224603B2 (da)
KR (1)	KR101530353B1 (da)
CN (1)	CN101511867B (da)
AT (1)	ATE490270T1 (da)
AU (1)	AU2007278894B2 (da)
BR (1)	BRPI0715331B8 (da)
CA (1)	CA2658806C (da)
CY (1)	CY1111630T1 (da)
DE (1)	DE602007010969D1 (da)
DK (1)	DK2076532T3 (da)
ES (1)	ES2361455T3 (da)
GB (1)	GB0614755D0 (da)
HR (1)	HRP20110146T1 (da)
ME (1)	ME01320B (da)
MX (1)	MX2009000918A (da)
NZ (1)	NZ575092A (da)
PL (1)	PL2076532T3 (da)
PT (1)	PT2076532E (da)
RS (1)	RS51854B (da)
RU (1)	RU2461567C2 (da)
SI (1)	SI2076532T1 (da)
WO (1)	WO2008012689A2 (da)
ZA (1)	ZA200901342B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT201600091033A1 (it) *	2016-09-08	2018-03-08	Bioimmunizer Sagl	Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CN112469430B (zh) *	2018-05-28	2024-12-24	日内瓦大学	抑制大脑炎症的方法
CA3101556A1 (en) *	2018-05-28	2019-12-05	ORION Biotechnology Switzerland Sarl	Ccr5 inhibitor for use in treating cancer
WO2024146707A1 (en)	2023-01-06	2024-07-11	Université De Genève	Variant ligand conjugates for payload delivery
WO2025172252A1 (en)	2024-02-15	2025-08-21	Novo Nordisk A/S	Protracted ccr5 antagonists and uses thereof
WO2025176787A1 (en)	2024-02-22	2025-08-28	Orion Biotechnology Holding Sa	Ccl5 variants for modulating gpr75
WO2025186255A1 (en)	2024-03-06	2025-09-12	Orion Biotechnology Holding Sa	Gipr inhibitors and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH08511007A (ja) *	1993-06-09	1996-11-19	コノートラボラトリーズリミテッド	タンデム合成ｈｉｖ−１ペプチド
FR2748938B1 (fr) *	1996-05-22	1998-07-31	Pasteur Institut	Utilisation de molecules antagonistes de chemokines pour leur activite antivirale notamment contre un retrovirus de type vih
UA77950C2 (en)	2000-10-04	2007-02-15	Applied Research Systems	Use of mutants of cc chemokines for treatment of multiple sclerosis
US20030049603A1 (en) *	2001-09-05	2003-03-13	Guy Gorochov	Methods for construction and screening of libraries of chemokine variants
US7442512B2 (en) *	2001-11-30	2008-10-28	Chemocentryx, Inc.	Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2005112567A2 (en)	2004-05-03	2005-12-01	University Of Maryland Biotechnology Institute	Vaginal microbicide

2006
- 2006-07-25 GB GBGB0614755.7A patent/GB0614755D0/en not_active Ceased
2007
- 2007-07-25 KR KR1020097003947A patent/KR101530353B1/ko active Active
- 2007-07-25 US US12/309,569 patent/US8686111B2/en active Active
- 2007-07-25 AT AT07825334T patent/ATE490270T1/de active
- 2007-07-25 JP JP2009521377A patent/JP5224603B2/ja active Active
- 2007-07-25 NZ NZ575092A patent/NZ575092A/en not_active IP Right Cessation
- 2007-07-25 CN CN200780032719.1A patent/CN101511867B/zh active Active
- 2007-07-25 HR HR20110146T patent/HRP20110146T1/hr unknown
- 2007-07-25 PT PT07825334T patent/PT2076532E/pt unknown
- 2007-07-25 EP EP07825334A patent/EP2076532B1/en active Active
- 2007-07-25 PL PL07825334T patent/PL2076532T3/pl unknown
- 2007-07-25 BR BRPI0715331A patent/BRPI0715331B8/pt active IP Right Grant
- 2007-07-25 RS RS20110103A patent/RS51854B/sr unknown
- 2007-07-25 CA CA2658806A patent/CA2658806C/en active Active
- 2007-07-25 AU AU2007278894A patent/AU2007278894B2/en active Active
- 2007-07-25 DE DE602007010969T patent/DE602007010969D1/de active Active
- 2007-07-25 WO PCT/IB2007/003026 patent/WO2008012689A2/en not_active Ceased
- 2007-07-25 DK DK07825334.1T patent/DK2076532T3/da active
- 2007-07-25 MX MX2009000918A patent/MX2009000918A/es active IP Right Grant
- 2007-07-25 ES ES07825334T patent/ES2361455T3/es active Active
- 2007-07-25 RU RU2009106436/10A patent/RU2461567C2/ru active
- 2007-07-25 SI SI200730500T patent/SI2076532T1/sl unknown
- 2007-07-25 ME MEP-2011-47A patent/ME01320B/me unknown
2009
- 2009-02-24 ZA ZA2009/01342A patent/ZA200901342B/en unknown
2011
- 2011-02-23 CY CY20111100216T patent/CY1111630T1/el unknown
2013
- 2013-06-04 US US13/909,845 patent/US9328153B2/en active Active

Also Published As

Publication number	Publication date
CA2658806C (en)	2017-01-03
US20130330305A1 (en)	2013-12-12
BRPI0715331B8 (pt)	2021-05-25
HK1131162A1 (en)	2010-01-15
BRPI0715331A2 (pt)	2013-07-16
ME01320B (me)	2013-12-20
AU2007278894A1 (en)	2008-01-31
RU2009106436A (ru)	2010-08-27
SI2076532T1 (sl)	2011-06-30
US20090317363A1 (en)	2009-12-24
HRP20110146T1 (hr)	2011-06-30
ZA200901342B (en)	2010-11-24
BRPI0715331B1 (pt)	2021-04-13
WO2008012689A2 (en)	2008-01-31
KR101530353B1 (ko)	2015-06-26
GB0614755D0 (en)	2006-09-06
RS51854B (sr)	2012-02-29
DE602007010969D1 (de)	2011-01-13
AU2007278894B2 (en)	2012-08-09
RU2461567C2 (ru)	2012-09-20
CN101511867A (zh)	2009-08-19
PT2076532E (pt)	2011-03-02
CA2658806A1 (en)	2008-01-31
NZ575092A (en)	2011-08-26
US8686111B2 (en)	2014-04-01
ES2361455T3 (es)	2011-06-17
ATE490270T1 (de)	2010-12-15
CN101511867B (zh)	2014-04-09
EP2076532B1 (en)	2010-12-01
MX2009000918A (es)	2009-08-26
WO2008012689A3 (en)	2008-05-08
PL2076532T3 (pl)	2011-07-29
JP5224603B2 (ja)	2013-07-03
JP2009544304A (ja)	2009-12-17
CY1111630T1 (el)	2015-10-07
EP2076532A2 (en)	2009-07-08
US9328153B2 (en)	2016-05-03
KR20090060281A (ko)	2009-06-11

Publication	Publication Date	Title
NZ600731A (en)	2014-06-27	Oxyntomodulin peptide analogue
NZ600690A (en)	2014-03-28	Fkbp-l and uses thereof
NZ627111A (en)	2015-10-30	Variants of activin iib receptor polypeptides and uses thereof
NZ600732A (en)	2014-06-27	Oxyntomodulin peptide analogue
IN2014CN02050A (da)	2015-05-29
EA201170878A1 (ru)	2012-01-30	Полипептиды с ксиланазной активностью
ATE417595T1 (de)	2009-01-15	Keratin-bindende polypeptide
NO20063026L (no)	2006-08-28	Antistoffer
UA103215C2 (uk)	2013-09-25	Поліпептид з ксиланазною активністю
WO2007115837B1 (en)	2008-03-27	Combination of an anti-edb fibronectin domain antibody/ il2 fusion protein and a further small molecule
ZA200901342B (en)	2010-11-24	Cytokine derivatives
NZ593550A (en)	2013-11-29	ANTI-Siglec-15 ANTIBODY
DE602006020032D1 (de)	2011-03-24	Il-21-varianten
NZ591612A (en)	2012-08-31	Prevention, treatment and diagnosis of p.gingivalis infection with peptides
MX2008009493A (es)	2008-10-03	Peptido novedoso y uso del mismo.
WO2010007144A3 (en)	2010-03-11	Mutated netrin-4 proteins, fragments thereof and their uses as drugs
DE602007004110D1 (de)	2010-02-11	Hausstaubmilbenallergen
NZ601647A (en)	2013-09-27	Variant hhip1 protein and methods and uses thereof
WO2010057242A3 (de)	2010-09-16	Vakzin
WO2008047370A3 (en)	2008-06-19	Compositions and methods for inducing angiogenesis
GEP20115196B (en)	2011-04-11	Neublastin variants
WO2006097432A3 (de)	2007-04-19	Keratin-biktdende desmoplakinpolypeptidsequenzen
DE602007006493D1 (de)	2010-06-24	Peptide mit proliferationshemmender wirkung
ATE441865T1 (de)	2009-09-15	Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
MY150639A (en)	2014-02-14	T cell adhesion molecule and antibody thereto